Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate

Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PL...

Full description

Bibliographic Details
Main Authors: Farideh Shiehzadeh, Mohsen Tafaghodi, Majid Laal-Dehghani, Faezeh Mashhoori, Bibi Sedigheh Fazly Bazzaz, Mohsen Imenshahidi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2019-06-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-25397
id doaj-d18853ab8435477682519971fe7b12c3
record_format Article
spelling doaj-d18853ab8435477682519971fe7b12c32020-11-24T20:43:21ZengTabriz University of Medical Sciences Advanced Pharmaceutical Bulletin2228-58812251-73082019-06-019225526110.15171/apb.2019.029apb-25397Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin SulfateFarideh Shiehzadeh0Mohsen Tafaghodi1Majid Laal-Dehghani2Faezeh Mashhoori3Bibi Sedigheh Fazly Bazzaz4Mohsen Imenshahidi5School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated. Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. In vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively. Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 µm and 39% respectively. Conclusion: In this study, dry powder formulation composed of PLGA LPPs encapsulating gentamicin sulfate showed a promising in vitro behavior as a pulmonary delivery carrier. Improvements on the aerodynamic behavior and in vivo evaluations recommended for further developments.https://apb.tbzmed.ac.ir/PDF/apb-25397AminoglycosidesDrug delivery systemsDry powder inhalersGentamicin sulfateLarge porous particlesLung
collection DOAJ
language English
format Article
sources DOAJ
author Farideh Shiehzadeh
Mohsen Tafaghodi
Majid Laal-Dehghani
Faezeh Mashhoori
Bibi Sedigheh Fazly Bazzaz
Mohsen Imenshahidi
spellingShingle Farideh Shiehzadeh
Mohsen Tafaghodi
Majid Laal-Dehghani
Faezeh Mashhoori
Bibi Sedigheh Fazly Bazzaz
Mohsen Imenshahidi
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
Advanced Pharmaceutical Bulletin
Aminoglycosides
Drug delivery systems
Dry powder inhalers
Gentamicin sulfate
Large porous particles
Lung
author_facet Farideh Shiehzadeh
Mohsen Tafaghodi
Majid Laal-Dehghani
Faezeh Mashhoori
Bibi Sedigheh Fazly Bazzaz
Mohsen Imenshahidi
author_sort Farideh Shiehzadeh
title Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
title_short Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
title_full Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
title_fullStr Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
title_full_unstemmed Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
title_sort preparation and characterization of a dry powder inhaler composed of plga large porous particles encapsulating gentamicin sulfate
publisher Tabriz University of Medical Sciences
series Advanced Pharmaceutical Bulletin
issn 2228-5881
2251-7308
publishDate 2019-06-01
description Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated. Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. In vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively. Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 µm and 39% respectively. Conclusion: In this study, dry powder formulation composed of PLGA LPPs encapsulating gentamicin sulfate showed a promising in vitro behavior as a pulmonary delivery carrier. Improvements on the aerodynamic behavior and in vivo evaluations recommended for further developments.
topic Aminoglycosides
Drug delivery systems
Dry powder inhalers
Gentamicin sulfate
Large porous particles
Lung
url https://apb.tbzmed.ac.ir/PDF/apb-25397
work_keys_str_mv AT faridehshiehzadeh preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
AT mohsentafaghodi preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
AT majidlaaldehghani preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
AT faezehmashhoori preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
AT bibisedighehfazlybazzaz preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
AT mohsenimenshahidi preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate
_version_ 1716820141757431808